A Single Dose of Viperfav(TM) May Be Inadequate for Vipera ammodytes Snake Bite: A Case Report and Pharmacokinetic Evaluation.

Toxins (Basel)

Centre for Research and Knowledge Transfer in Biotechnology, University of Zagreb, Rockefellerova 10, HR-10000 Zagreb, Croatia.

Published: August 2016

Viperfav(TM) is a commercial F(ab')₂ antivenom prepared against European vipers venom. It is safe and effective for treating envenomation caused by Vipera aspis and Vipera berus. Therapeutic efficacy for treating Vipera ammodytes ammodytes (V. a. ammodytes) envenoming has not been yet described, although protective efficacy has been demonstrated in preclinical studies. We report on a 32-year-old man bitten by V. a. ammodytes who was treated with Viperfav™. Viperfav™ promptly reduced local extension and improved systemic pathological signs, but 24 h after the incident a recurrence of thrombocytopenia occurred despite a favorable pharmacokinetic profile with systemic clearance (1.64 (mL·h(-1))·kg(-1)) and elimination half-life (97 h) among the highest ever reported. The recommended dose of Viperfav™ for V. aspis and V. berus bites may be inadequate for serious V. a. ammodytes envenomations. Following V. a. ammodytes bite, serial blood counts and coagulation profiles should be performed to help guide Viperfav™ treatment, along with supplemental administration as indicated.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999860PMC
http://dx.doi.org/10.3390/toxins8080244DOI Listing

Publication Analysis

Top Keywords

vipera ammodytes
8
ammodytes ammodytes
8
ammodytes
7
single dose
4
dose viperfavtm
4
viperfavtm inadequate
4
vipera
4
inadequate vipera
4
ammodytes snake
4
snake bite
4

Similar Publications

The Venom of : Proteomics, Neurotoxic Effect and Neutralization by Antivenom.

Vet Sci

November 2024

Department of Chemistry, Faculty of Veterinary Medicine, University of Belgrade, Bulevar Oslobođenja 18, 11000 Belgrade, Serbia.

Deep proteomic analyses identified, in total, 159 master proteins (with 1% FDR and 2 unique peptides) from 26 protein families in the venom of Data are available via ProteomeXchange with the identifier PXD056495. The relative abundance of PLA2s is 11.60% of the crude venom, of which 4.

View Article and Find Full Text PDF

Assessment of the Linnaean type material of the Nose-horned viper, Vipera ammodytes (Linnaeus, 1758).

Zootaxa

November 2024

Swedish Museum of Natural History; Department of Zoology; PO Box 50007; SE-10405 Stockholm; Sweden.

Within the framework of surveys investigating the origins of Linnaean taxa, we assessed the evidence supporting historical taxonomic and nomenclatural proposals and decisions regarding the nose-horned viper (Vipera ammodytes). The viper was described as Coluber ammodytes Linnaeus, 1758 from "the Orient." Bruno (1968) assessed the pre-Systema Naturae Ed.

View Article and Find Full Text PDF

Introduction: Alternative in vitro tests that can be used instead of animal experiments are those that can most closely evaluate the biological activity of the drug of interest. For testing the potency of antivenom, these are the methods used to assess cytotoxicity. The aim of this study was to evaluate the most commonly used cytotoxicity methods for determining the protective potency of the antivenom Viekvin, which neutralizes Vipera ammodytes venom.

View Article and Find Full Text PDF

Physiological costs of warning: Defensive hissing increases metabolic rate and evaporative water loss in a venomous snake.

Physiol Behav

December 2024

Centre d'Etudes Biologiques de Chizé-La Rochelle, CEBC-CNRS UMR7372, 79360, Villiers en Bois, France; School of Life Sciences, Arizona State University, Tempe, AZ, USA.

To minimize predation risk and the cost of confronting predators, prey have developed a range of defensive strategies and warning signals. Although advantageous, defensive warnings may also induce physiological and energy costs to the emitter. Ventilatory sounds (hissing) are the most distributed warning sound in vertebrates.

View Article and Find Full Text PDF
Article Synopsis
  • The Eastern Long-Nosed Viper is one of Europe's most venomous snakes, and this study investigates how its venom varies from neonate (young) to adult stages, particularly in terms of procoagulant effects on human plasma.
  • Findings show that neonate venom is more potent in activating blood-clotting factors compared to adult venom, challenging previous assumptions about venom effects based solely on adult specimens.
  • Although all tested antivenoms can neutralize both venom types, they are generally more effective against adult venom, highlighting the need for further research on clinical implications of the observed venom variations.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!